NRF2/KEAP1 signaling inhibitors in gynecologic cancers

Expert Rev Anticancer Ther. 2024 Dec;24(12):1191-1194. doi: 10.1080/14737140.2024.2438951. Epub 2024 Dec 7.

Authors

Sonia Fantone¹, Daniela Marzioni^{2

3}, Giovanni Tossetta³

Affiliations

¹ Scientific Direction, IRCCS INRCA, Ancona, Italy.
² IRCCS INRCA, Ancona, Italy.
³ Department of Experimental and Clinical Medicine, Università Politecnica delle Marche, Ancona, Italy.

PMID: 39636348
DOI: 10.1080/14737140.2024.2438951

No abstract available

Keywords: Cervical cancer; NRF2; endometrial cancer; gynecologic cancer; inhibitors; ovarian cancer.

Publication types

Editorial